Cascades Capital Asset Management, LLC

Position in AMGN — Amgen Inc

CIK 2035512 GREENSBORO, NC

Position in AMGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$777,109

+$22,039 QoQ

Shares Held

2,146

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.54%

of 13F equity value

Holder Rank

#1,871

of 3,140 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cascades Capital Asset Management, LLC holds $6,734,291 across 6 Drug Manufacturers - General names. AMGN ranks #4 (11.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,539	$3,045,353
2	ABBV	AbbVie Inc.	5,690	$1,431,831
3	JNJ	Johnson & Johnson	3,461	$878,990
4	AMGN	Amgen Inc This page	2,146	$777,109
5	MRK	Merck & Co., Inc.	3,016	$387,556
6	NVS	Novartis AG	1,362	$213,452

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$777,109	2,146	0.0%	Shares	Sole	2026-08-14
2026-03-31	$755,070	2,146	0.0%	Shares	Sole	2026-05-15
2025-12-31	$702,407	2,146	+0.4%	Shares	Sole	2026-02-04
2025-09-30	$603,343	2,138	-1.9%	Shares	Sole	2025-11-14
2025-06-30	$608,398	2,179	+3.1%	Shares	Sole	2025-08-14
2025-03-31	$658,616	2,114	0.0%	Shares	Sole	2025-05-15
2024-12-31	$550,992	2,114	0.0%	Shares	Sole	2025-02-13
2024-09-30	$681,151	2,114	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.